The CRM model can non-invasively predict the prognosis of HCC patients treated by TACE therapy.
Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study
Yusheng Guo·Xuefeng Kan·Sanmu Li·Lin Yang·Yuxin Sun·Kai Zhao·Bo Liang·Lei Yu·XUEGANG YANG·Qiuping Liu·Yudong Zhang·Hua Zhao·Guilin Zhang·Yi Li·Jiahua Zou·Xuhua Duan·Xiaolin Zhang·Chang Zhao·Rong Ding·Chuansheng Zheng·Xiaofang Guo·Xiaona Fu·Sha Jiang